Login
Evidence Feed
About
Conferences
New
Diagnostics
New
Top genes
New
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
PDGFR inhibitor
DRUG CLASS:
PDGFR inhibitor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
imatinib (165)
sunitinib (128)
TKI258 (9)
MLN518 (8)
CS 2164 (1)
X-82 (1)
imatinib (165)
sunitinib (128)
TKI258 (9)
MLN518 (8)
CS 2164 (1)
X-82 (1)
›
Associations
(314)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
KIT positive
Gastrointestinal Stromal Tumor
KIT positive
Gastrointestinal Stromal Tumor
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
No biomarker
Neuroendocrine Tumor
No biomarker
Neuroendocrine Tumor
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
BCR-ABL1 fusion
Acute Lymphocytic Leukemia
BCR-ABL1 fusion
Acute Lymphocytic Leukemia
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
No biomarker
Renal Cell Carcinoma
No biomarker
Renal Cell Carcinoma
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
No biomarker
Gastrointestinal Stromal Tumor
No biomarker
Gastrointestinal Stromal Tumor
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
No biomarker
Neuroendocrine Tumor
No biomarker
Neuroendocrine Tumor
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
sunitinib
Sensitive: A1 - Approval
sunitinib
Sensitive
:
A1
BCR-ABL1 fusion
Chronic Myeloid Leukemia
BCR-ABL1 fusion
Chronic Myeloid Leukemia
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
No biomarker
Fibrosarcoma
No biomarker
Fibrosarcoma
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
KIT expression
Gastrointestinal Stromal Tumor
KIT expression
Gastrointestinal Stromal Tumor
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
FIP1L1-PDGFRA fusion
Chronic Eosinophilic Leukemia
FIP1L1-PDGFRA fusion
Chronic Eosinophilic Leukemia
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
PDGFRA rearrangement
Myelodysplastic Syndrome
PDGFRA rearrangement
Myelodysplastic Syndrome
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
imatinib
Sensitive: A1 - Approval
imatinib
Sensitive
:
A1
KIT mutation
Thymic Carcinoma
KIT mutation
Thymic Carcinoma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
No biomarker
Meningioma
No biomarker
Meningioma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
No biomarker
Chordoma
No biomarker
Chordoma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
BCR-ABL1 fusion
B Acute Lymphoblastic Leukemia
BCR-ABL1 fusion
B Acute Lymphoblastic Leukemia
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
PDGFRA exon 18 mutation
Gastrointestinal Stromal Tumor
PDGFRA exon 18 mutation
Gastrointestinal Stromal Tumor
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
No biomarker
Gastrointestinal Stromal Tumor
No biomarker
Gastrointestinal Stromal Tumor
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
No biomarker
Childhood B Acute Lymphoblastic Leukemia
No biomarker
Childhood B Acute Lymphoblastic Leukemia
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
No biomarker
Sarcoma
No biomarker
Sarcoma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
No biomarker
Clear Cell Renal Cell Carcinoma
No biomarker
Clear Cell Renal Cell Carcinoma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
KIT exon 11 mutation
Melanoma
KIT exon 11 mutation
Melanoma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
KIT exon 13 mutation
Melanoma
KIT exon 13 mutation
Melanoma
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
sunitinib
Sensitive: A2 - Guideline
sunitinib
Sensitive
:
A2
PDGFRA D842V
Gastric Cancer
PDGFRA D842V
Gastric Cancer
imatinib
Resistant: A2 - Guideline
imatinib
Resistant
:
A2
imatinib
Resistant: A2 - Guideline
imatinib
Resistant
:
A2
KIT K642E
Cutaneous Melanoma
KIT K642E
Cutaneous Melanoma
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
KIT L576P
Cutaneous Melanoma
KIT L576P
Cutaneous Melanoma
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
KIT V559
Cutaneous Melanoma
KIT V559
Cutaneous Melanoma
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
KIT W557
Cutaneous Melanoma
KIT W557
Cutaneous Melanoma
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
No biomarker
Chordoma
No biomarker
Chordoma
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
No biomarker
Colorectal Cancer
No biomarker
Colorectal Cancer
sunitinib
Resistant: A2 - Guideline
sunitinib
Resistant
:
A2
sunitinib
Resistant: A2 - Guideline
sunitinib
Resistant
:
A2
KIT mutation
Cutaneous Melanoma
KIT mutation
Cutaneous Melanoma
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
imatinib
Sensitive: A2 - Guideline
imatinib
Sensitive
:
A2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login